References
- Shaw E G, Scheithauer B W, Suman V, Katzman J. Association of cell proliferation (%S, %G2M) and histologic grade with survival of oligodendrogliomas. J Neuro-Oncol, (abstract) (in press)
- Kros J M, VanEden C G, Vissers C H, Mulder A H, Van der Kwast. Prognostic relevance of DNA flow cytometry in oligodendroglioma. Cancer 1992; 69: 1791–1798
- Coons S W, Johnson P C, Pearl D K, Olafsen A G. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. Neurosurgery, 34: 680–687
- Ransom D T, Ritland S R, Kimmel D W, Moertel C A, Dahl R J, Scheithauer B W, Kelly P J, Jenkins R B. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chrom Cancer 1992; 5: 348–356
- Ritland S R, Ganju V, Jenkins R B. Region specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chrom Cancer, (in press)
- Ganju V, Jenkins R B, O'Fallon J R, Scheithauer B W, Ransom J A, Kimmel D W. Prognostic factors in gliomas: A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic and molecular markers. Cancer 1994; 74: 920–927